MedTrace Logo

C-X-C Chemokine Receptor 4 in Chronic Lymphocytic Leukemia

NCT03150849 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2017-05-12

No results posted yet for this study

Summary

Chronic lymphocytic leukemia is the most common type of chronic leukemia, accounting for approximately 40% of all leukemias and mainly affecting older individuals. As it has a highly variable clinical course, identification of molecular and biological prognostic markers has provided new insights into the risk stratification of patients with chronic lymphocytic leukemia.

Conditions

Interventions

DIAGNOSTIC_TEST

C-X-C Chemokine Receptor 4

marker assessed by flowcytometry in a blood sample

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2019-07-01
Completion
2019-12-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03150849 on ClinicalTrials.gov